Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K142664Substantially Equivalent

URight Hemoglobin A1c system, FORA A1c System

Taidoc Technology Corporation, New Taipei City, TW / Traditional, Substantially Equivalent

K142664 is the FDA 510(k) clearance record for URight Hemoglobin A1c system, FORA A1c System, a class II device, cleared for Taidoc Technology Corporation on under FDA product code LCP (Assay, Glycosylated Hemoglobin). FDA records list 123 510(k) clearances for Taidoc Technology Corporation, from to . As of , FDA records show no recalls naming K142664.

Clearance record

Decision date
Received
(498 days to decision)
Product code
LCP Assay, Glycosylated Hemoglobin
Regulation
21 CFR 864.7470
Device class
Class II
Review panel
Hematology
Applicant
Taidoc Technology Corporation B1-7f, #127, Wugong 2nd Rd., New Taipei City, TW
510(k) summary
Summary PDF
Third party review
No

Clearances, product code LCP

Trailing 12 months

FDA records hold no clearances under product code LCP in the trailing twelve months.

FDA records show no clearances under product code LCP in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LCP, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260